Drug Profile
PF 184298
Alternative Names: PF-184298Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anilides; Pyrrolidines; Small molecules
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Stress incontinence
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Stress-incontinence in United Kingdom (PO)
- 18 Apr 2007 Phase-I clinical trials in Stress incontinence in United Kingdom (PO)